MedTrace Logo

Sodium Channel Mutations in Patient With the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)

NCT05877274 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-10-30

No results posted yet for this study

Summary

The goal of this observational study is to learn about sodium channel (Nav) mutations in patients with the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES). This study will give more insight into the pathophysiology of ACNES, which is still largely unknown.

The primary objective is to determine if there are mutations of Nav1.7 and Nav1.8 in patients with ACNES. Therefore, one blood sample will be drawn, in which the mutations will be analyzed.

Conditions

  • Anterior Cutaneous Nerve Entrapment Syndrome
  • Nerve Entrapment Syndrome
  • Chronic Pain Syndrome

Interventions

OTHER

Sodium channel mutation

Mutation of the genes SCN9A and SCN10A, which encode for Sodium channel 1.7 and 1.8.

Sponsors & Collaborators

  • Maxima Medical Center

    lead OTHER

Principal Investigators

  • Rudi Roumen, MD, PhD · Maxima Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-03
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05877274 on ClinicalTrials.gov